Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,778 public trials 1,525 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • University of Alabama_6th Ave Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 53 locations
View Trial Details
Recruiting

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

NCT06964009

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

NCT06952504

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 6033) Mobile, Alabama, United States
  • Alaska Women's Cancer Care ( Site 6036) Anchorage, Alaska, United States
  • CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014) Irvine, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020) Orange, California, United States
View all 263 locations
View Trial Details
Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

NCT07318558

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Mount Sinai Cancer Center ( Site 0029) Miami Beach, Florida, United States
  • Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085) Orlando, Florida, United States
  • Winship Cancer Institute of Emory University ( Site 0037) Atlanta, Georgia, United States
  • Illinois Cancer Specialists (ICS) ( Site 8009) Arlington Heights, Illinois, United States
View all 162 locations
View Trial Details
Recruiting

Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis

NCT06955221

Conditions
Endometrioma, Endometriosis, Female Urogenital Diseases, +11 more
Locations
  • Hospital Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitario Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital General de Granollers Granollers, Barcelona, Spain
  • Consorci Sanitari de l'Anoia Igualada, Barcelona, Spain
View all 29 locations
View Trial Details
Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

NCT06303505

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +22 more
Locations
  • The University of Alabama Birmingham, Alabama, United States
  • Mount Sinai New York, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 29 locations
View Trial Details
Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

NCT05256225

Conditions
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 414 locations
View Trial Details
Recruiting

Vaginal Microbiota Transplant

NCT04046900

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions